ID   UBE2O_HUMAN             Reviewed;        1292 AA.
AC   Q9C0C9; A6NDU5; Q69YP4; Q6PIZ2; Q86UA4; Q8N425; Q8TBN1; Q9BSW1;
AC   Q9H6E6; Q9H7E4; Q9H9B2;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 3.
DT   10-MAY-2017, entry version 136.
DE   RecName: Full=(E3-independent) E2 ubiquitin-conjugating enzyme;
DE            EC=2.3.2.24 {ECO:0000269|PubMed:23455153, ECO:0000269|PubMed:24703950};
DE   AltName: Full=E2/E3 hybrid ubiquitin-protein ligase UBE2O;
DE   AltName: Full=Ubiquitin carrier protein O;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2 O;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2 of 230 kDa;
DE            Short=Ubiquitin-conjugating enzyme E2-230K;
DE   AltName: Full=Ubiquitin-protein ligase O;
GN   Name=UBE2O; Synonyms=KIAA1734;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-1207.
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 270-1292, AND VARIANT
RP   SER-1207.
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 338-1292, AND VARIANT
RP   SER-1207.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 448-1292, AND VARIANT
RP   SER-1207.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=11311559; DOI=10.1016/S0378-1119(01)00407-3;
RA   Yokota T., Nagai H., Harada H., Mine N., Terada Y., Fujiwara H.,
RA   Yabe A., Miyazaki K., Emi M.;
RT   "Identification, tissue expression, and chromosomal position of a
RT   novel gene encoding human ubiquitin-conjugating enzyme E2-230k.";
RL   Gene 267:95-100(2001).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399; SER-401; SER-441
RP   AND SER-836, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87 AND SER-836, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87 AND SER-89, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; SER-89 AND SER-896,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   FUNCTION.
RX   PubMed=23452853; DOI=10.1016/j.cell.2013.01.051;
RA   Hao Y.H., Doyle J.M., Ramanathan S., Gomez T.S., Jia D., Xu M.,
RA   Chen Z.J., Billadeau D.D., Rosen M.K., Potts P.R.;
RT   "Regulation of WASH-dependent actin polymerization and protein
RT   trafficking by ubiquitination.";
RL   Cell 152:1051-1064(2013).
RN   [16]
RP   FUNCTION.
RX   PubMed=23381138; DOI=10.1038/cr.2013.21;
RA   Zhang X., Zhang J., Zhang L., van Dam H., ten Dijke P.;
RT   "UBE2O negatively regulates TRAF6-mediated NF-kappaB activation by
RT   inhibiting TRAF6 polyubiquitination.";
RL   Cell Res. 23:366-377(2013).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF CYS-1040.
RX   PubMed=23455153; DOI=10.1038/emboj.2013.38;
RA   Zhang X., Zhang J., Bauer A., Zhang L., Selinger D.W., Lu C.X.,
RA   Ten Dijke P.;
RT   "Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated
RT   monoubiquitination of SMAD6.";
RL   EMBO J. 32:996-1007(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; SER-89; SER-399;
RP   SER-401; SER-515; SER-836 AND SER-896, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-87; SER-89;
RP   THR-488 AND THR-491, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, ENZYME REGULATION,
RP   PHOSPHORYLATION, UBIQUITINATION, NUCLEAR LOCALIZATION SIGNAL, AND
RP   MUTAGENESIS OF CYS-1040.
RX   PubMed=24703950; DOI=10.1016/j.molcel.2014.03.002;
RA   Mashtalir N., Daou S., Barbour H., Sen N.N., Gagnon J.,
RA   Hammond-Martel I., Dar H.H., Therrien M., Affar E.B.;
RT   "Autodeubiquitination protects the tumor suppressor BAP1 from
RT   cytoplasmic sequestration mediated by the atypical ubiquitin ligase
RT   UBE2O.";
RL   Mol. Cell 54:392-406(2014).
CC   -!- FUNCTION: E2/E3 hybrid ubiquitin-protein ligase that displays both
CC       E2 and E3 ligase activities and mediates monoubiquitination of
CC       target proteins (PubMed:23455153, PubMed:24703950). Negatively
CC       regulates TRAF6-mediated NF-kappa-B activation independently of
CC       its E2 activity (PubMed:23381138). Acts as a positive regulator of
CC       BMP7 signaling by mediating monoubiquitination of SMAD6, thereby
CC       regulating adipogenesis (PubMed:23455153). Mediates
CC       monoubiquitination at different sites of the nuclear localization
CC       signal (NLS) of BAP1, leading to cytoplasmic retention of BAP1.
CC       Also able to monoubiquitinate the NLS of other chromatin-
CC       associated proteins, such as INO80 and CXXC1, affecting their
CC       subcellular location (PubMed:24703950). Acts as a regulator of
CC       retrograde transport by assisting the TRIM27:MAGEL2 E3 ubiquitin
CC       ligase complex to mediate 'Lys-63'-linked ubiquitination of
CC       WASHC1, leading to promote endosomal F-actin assembly
CC       (PubMed:23452853). {ECO:0000269|PubMed:23381138,
CC       ECO:0000269|PubMed:23452853, ECO:0000269|PubMed:23455153,
CC       ECO:0000269|PubMed:24703950}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-
CC       activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000255|PROSITE-ProRule:PRU00388,
CC       ECO:0000269|PubMed:23455153, ECO:0000269|PubMed:24703950}.
CC   -!- ENZYME REGULATION: inhibited by phenylarsine oxide (PAO).
CC       {ECO:0000269|PubMed:24703950}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with CPNE1 (via VWFA domain) and CPNE4 (via
CC       VWFA domain). {ECO:0000250|UniProtKB:Q6ZPJ3}.
CC   -!- INTERACTION:
CC       Q9UKG1:APPL1; NbExp=5; IntAct=EBI-2339946, EBI-741243;
CC       Q5VUG0:SFMBT2; NbExp=4; IntAct=EBI-2339946, EBI-12025260;
CC       O35182:Smad6 (xeno); NbExp=4; IntAct=EBI-2339946, EBI-4321242;
CC       O35253:Smad7 (xeno); NbExp=2; IntAct=EBI-2339946, EBI-5274835;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24703950}.
CC       Nucleus {ECO:0000269|PubMed:24703950}. Note=Mainly localizes to
CC       the cytoplasm.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in skeletal muscle and
CC       heart. {ECO:0000269|PubMed:11311559}.
CC   -!- PTM: Phosphorylated. Phosphorylation affects subcellular location.
CC       {ECO:0000269|PubMed:24703950}.
CC   -!- PTM: Ubiquitinated: autoubiquitinates, possibly affecting its
CC       subcellular location. {ECO:0000269|PubMed:24703950}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22237.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH25977.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH36820.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH51868.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB14320.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB14948.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB15313.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB21825.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB051521; BAB21825.1; ALT_INIT; mRNA.
DR   EMBL; AC090699; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89396.1; -; Genomic_DNA.
DR   EMBL; BC004525; AAH04525.2; -; mRNA.
DR   EMBL; BC022237; AAH22237.1; ALT_INIT; mRNA.
DR   EMBL; BC025977; AAH25977.1; ALT_INIT; mRNA.
DR   EMBL; BC036820; AAH36820.1; ALT_INIT; mRNA.
DR   EMBL; BC051868; AAH51868.2; ALT_INIT; mRNA.
DR   EMBL; AL832432; CAH10644.1; -; mRNA.
DR   EMBL; AK022940; BAB14320.1; ALT_INIT; mRNA.
DR   EMBL; AK024657; BAB14948.1; ALT_INIT; mRNA.
DR   EMBL; AK025999; BAB15313.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32742.1; -.
DR   RefSeq; NP_071349.3; NM_022066.3.
DR   UniGene; Hs.16130; -.
DR   ProteinModelPortal; Q9C0C9; -.
DR   SMR; Q9C0C9; -.
DR   BioGrid; 121973; 85.
DR   IntAct; Q9C0C9; 36.
DR   STRING; 9606.ENSP00000323687; -.
DR   iPTMnet; Q9C0C9; -.
DR   PhosphoSitePlus; Q9C0C9; -.
DR   BioMuta; UBE2O; -.
DR   DMDM; 209572710; -.
DR   EPD; Q9C0C9; -.
DR   MaxQB; Q9C0C9; -.
DR   PaxDb; Q9C0C9; -.
DR   PeptideAtlas; Q9C0C9; -.
DR   PRIDE; Q9C0C9; -.
DR   Ensembl; ENST00000319380; ENSP00000323687; ENSG00000175931.
DR   GeneID; 63893; -.
DR   KEGG; hsa:63893; -.
DR   UCSC; uc002jrm.5; human.
DR   CTD; 63893; -.
DR   GeneCards; UBE2O; -.
DR   H-InvDB; HIX0020035; -.
DR   HGNC; HGNC:29554; UBE2O.
DR   HPA; HPA023605; -.
DR   neXtProt; NX_Q9C0C9; -.
DR   OpenTargets; ENSG00000175931; -.
DR   PharmGKB; PA142670651; -.
DR   eggNOG; KOG0895; Eukaryota.
DR   eggNOG; ENOG410XQ7W; LUCA.
DR   GeneTree; ENSGT00730000110680; -.
DR   HOVERGEN; HBG080116; -.
DR   InParanoid; Q9C0C9; -.
DR   KO; K10581; -.
DR   OMA; IAWECPE; -.
DR   OrthoDB; EOG091G04SX; -.
DR   PhylomeDB; Q9C0C9; -.
DR   TreeFam; TF325556; -.
DR   BioCyc; MetaCyc:HS10987-MONOMER; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9C0C9; -.
DR   SIGNOR; Q9C0C9; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2O; human.
DR   GeneWiki; UBE2O; -.
DR   GenomeRNAi; 63893; -.
DR   PRO; PR:Q9C0C9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000175931; -.
DR   CleanEx; HS_UBE2O; -.
DR   ExpressionAtlas; Q9C0C9; baseline and differential.
DR   Genevisible; Q9C0C9; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:FlyBase.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IDA:MGI.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IMP:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Coiled coil; Complete proteome; Cytoplasm;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Transport; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1   1292       (E3-independent) E2 ubiquitin-conjugating
FT                                enzyme.
FT                                /FTId=PRO_0000280637.
FT   COILED      812    882       {ECO:0000255}.
FT   MOTIF       512    536       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:24703950}.
FT   COMPBIAS      2     43       Ala-rich.
FT   ACT_SITE   1040   1040       Glycyl thioester intermediate.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     399    399       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     401    401       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     441    441       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     488    488       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     491    491       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     515    515       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     836    836       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     838    838       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q6ZPJ3}.
FT   MOD_RES     839    839       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6ZPJ3}.
FT   MOD_RES     896    896       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT    1207   1207       G -> S (in dbSNP:rs3803739).
FT                                {ECO:0000269|PubMed:11214970,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_031184.
FT   MUTAGEN    1040   1040       C->S: Loss of function.
FT                                {ECO:0000269|PubMed:23455153,
FT                                ECO:0000269|PubMed:24703950}.
FT   CONFLICT     50     50       S -> F (in Ref. 1; BAB21825).
FT                                {ECO:0000305}.
FT   CONFLICT    675    675       E -> EQ (in Ref. 6; BAB15313).
FT                                {ECO:0000305}.
FT   CONFLICT   1047   1047       W -> C (in Ref. 4; AAH22237).
FT                                {ECO:0000305}.
FT   CONFLICT   1143   1143       E -> D (in Ref. 4; AAH25977).
FT                                {ECO:0000305}.
FT   CONFLICT   1150   1150       A -> T (in Ref. 6; BAB14320).
FT                                {ECO:0000305}.
FT   CONFLICT   1261   1261       L -> P (in Ref. 6; BAB14320).
FT                                {ECO:0000305}.
FT   CONFLICT   1290   1290       E -> G (in Ref. 6; BAB14948).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1292 AA;  141293 MW;  C9DF6395A32E9AB0 CRC64;
     MADPAAPTPA APAPAQAPAP APEAVPAPAA APVPAPAPAS DSASGPSSDS GPEAGSQRLL
     FSHDLVSGRY RGSVHFGLVR LIHGEDSDSE GEEEGRGSSG CSEAGGAGHE EGRASPLRRG
     YVRVQWYPEG VKQHVKETKL KLEDRSVVPR DVVRHMRSTD SQCGTVIDVN IDCAVKLIGT
     NCIIYPVNSK DLQHIWPFMY GDYIAYDCWL GKVYDLKNQI ILKLSNGARC SMNTEDGAKL
     YDVCPHVSDS GLFFDDSYGF YPGQVLIGPA KIFSSVQWLS GVKPVLSTKS KFRVVVEEVQ
     VVELKVTWIT KSFCPGGTDS VSPPPSVITQ ENLGRVKRLG CFDHAQRQLG ERCLYVFPAK
     VEPAKIAWEC PEKNCAQGEG SMAKKVKRLL KKQVVRIMSC SPDTQCSRDH SMEDPDKKGE
     SKTKSEAESA SPEETPDGSA SPVEMQDEGA EEPHEAGEQL PPFLLKEGRD DRLHSAEQDA
     DDEAADDTDD TSSVTSSASS TTSSQSGSGT SRKKSIPLSI KNLKRKHKRK KNKITRDFKP
     GDRVAVEVVT TMTSADVMWQ DGSVECNIRS NDLFPVHHLD NNEFCPGDFV VDKRVQSCPD
     PAVYGVVQSG DHIGRTCMVK WFKLRPSGDD VELIGEEEDV SVYDIADHPD FRFRTTDIVI
     RIGNTEDGAP HKEDEPSVGQ VARVDVSSKV EVVWADNSKT IILPQHLYNI ESEIEESDYD
     SVEGSTSGAS SDEWEDDSDS WETDNGLVED EHPKIEEPPI PPLEQPVAPE DKGVVISEEA
     ATAAVQGAVA MAAPMAGLME KAGKDGPPKS FRELKEAIKI LESLKNMTVE QLLTGSPTSP
     TVEPEKPTRE KKFLDDIKKL QENLKKTLDN VAIVEEEKME AVPDVERKED KPEGQSPVKA
     EWPSETPVLC QQCGGKPGVT FTSAKGEVFS VLEFAPSNHS FKKIEFQPPE AKKFFSTVRK
     EMALLATSLP EGIMVKTFED RMDLFSALIK GPTRTPYEDG LYLFDIQLPN IYPAVPPHFC
     YLSQCSGRLN PNLYDNGKVC VSLLGTWIGK GTERWTSKSS LLQVLISIQG LILVNEPYYN
     EAGFDSDRGL QEGYENSRCY NEMALIRVVQ SMTQLVRRPP EVFEQEIRQH FSTGGWRLVN
     RIESWLETHA LLEKAQALPN GVPKASSSPE PPAVAELSDS GQQEPEDGGP APGEASQGSD
     SEGGAQGLAS ASRDHTDQTS ETAPDASVPP SVKPKKRRKS YRSFLPEKSG YPDIGFPLFP
     LSKGFIKSIR GVLTQFRAAL LEAGMPECTE DK
//
